Cristina Freitas*; Fernanda Silva*; Norton de Matos**; Rui Machado**; José Queirós*; Rui Almeida**, António Cabrita*
* Serviço de Nefrologia, Hospital de Santo António; Porto; Portugal
** Serviço de Cirurgia Vascular, Hospital de Santo António; Porto; Portugal
|RESUMO|
Introdução: Os acessos vasculares são responsáveis por elevada morbilidade nos doentes em hemodiálise. A fístula arteriovenosa (FAV) representa o acesso vascular com menor taxa de complicações, pelo que a Consulta de Acessos Vasculares para hemodiálise procura promover o aumento da sua taxa de patência.
Métodos: avaliação retrospectiva dos motivos de referenciação à consulta entre 01-01-2008 e 31-12-2009, do resultado das intervenções e análise dos factores relacionados com a patência da FAV.
]]> Resultados: Avaliaram-se 697 doentes (58% homens, 30% diabéticos, idade média 64±15 anos) referenciados para construção de acesso (71%), suspeita de estenose (14%), síndrome de roubo (6%) pseudoaneurismas (4%) e hipertensão venosa (HTV) (3%). Os acessos construídos foram FAV simples (n=514; 91% dos doentes), transposição da veia basílica (n=40) e pontagem arteriovenosa com prótese (n=10). A taxa de patência global (às 4 semanas) foi 83% (75%, 93% e 40% respectivamente nas FAVs, transposições e pontagens). A localização proximal da FAV (p <0,01) e avaliação pré-operatória por Dopller (p=0,02) associaram-se a melhor resultado. As estenoses da FAV foram tratadas por angioplastia, endovascular (45%) e cirúrgica (23%), com patência de 95% e 90% respectivamente. O síndrome de roubo foi tratado por redução do débito com banding em 57% dos casos (sucesso 84%) e laqueação da FAV em 16%. A angioplastia endovascular efectuou-se em 57% das HTV com sucesso de 84%. Em 50% dos pseudoaneurismas realizou-se aneurismectomia com manutenção da função da FAV em 90%.Conclusão: Resultados das intervenções sobreponíveis aos das séries internacionais. A avaliação pré-operatória por Ecodoppler favoreceu a patência da FAV.
Palavras-chave: Fístula arteriovenosa, Hemodiálise, Ecodoppler
Outpatient clinic for vascular access in hemodialysis patients – A single-centre experience
|ABSTRACT|
Background: The vascular access is responsible for high morbidity in for hemodialysis patients. Arteriovenous fistula (AVF) provides the vascular access with lower complication rate, so the Consulta de Acessos Vasculares for hemodialysis promotes actions to increase its patency rate.
Methods: Retrospective study of the causes for referral to consultation between 01/01/2008 and 31/12/2009, outcome of proposed interventions and factors favoring AVF patency.
Results: We evaluated 697 patients (58% male, 30% diabetic, mean age 64 ± 15 years) referred for construction of access (71%), suspicion of stenosis (14%), steal syndrome (6%), pseudoaneurysm (4%) and venous hypertension (HTV) (3%). The constructed access were simple AVF (n=514, 91% of patients, transposition of the basilic vein (n=40) and prothesic arteriovenous graft (n=10). The global access patency rate (at 4th week) was 83% (with 75%, 93%, 40% for AVFs, transposition and grafts, respectively). Proximal location of AVF (p <0.01) and preoperative Doppler evaluation (p = 0.02) were associated with better outcomes. AVF venous stenosis was treated with angioplasty, endovascular (45%) and surgical (23%), with patency rates of 95% and 90%, respectively. The steal syndrome was treated by AVF reduction with banding in 57% of cases (84% success) and AVF ligation in 16%. Endovascular angioplasty was preformed in 57% of cases of HTV (success of 84%). Aneurysmectomy was performed in 50% of patients with pseudoaneurysms with preservation of AVF patency in 90% of cases.
Conclusion: Interventions outcomes were similar to those of international studies. Preoperative evaluation by Doppler ultrasound improved the AVF patency.
]]> Key words: artteriovenous fistula, hemodialysis, ecodoppler
Texto completo disponível apenas em PDF.
Full text only available in PDF format.
BIBLIOGRAFIA
[1] Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in United States. Kidney Int, 1993; 43 (5): 1091-1096
[2] Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. Type of vascular access and survival among incident hemodialysis patients: the CHOICE Study. J Am Soc Nephrol 2005: 16 (5): 1449-1451
[3] Armada E, Trillo M, Pérez Melón C et al. Monitoring protocol of native vascular accesses for haemodialysis. Nefrologia. 2005;25(1):57-66. [ Links ]
[4] Elseviers MM, Van Waeleghem JP. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Nephrol News Issues. 2003;17(8):61-4, 66-8, 99.
]]> [5] Wasse H. Catheter-related mortality among ESRD patients. Semin Dial 2008; 21 (6): 547-549[6] Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48 (S1): S248 -273
[7] Lok CE, Oliver MJ, Su J, Bhola C, Hannigan N, Jassal SV. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int. 2005; 67(6):2462-9.
[8] Weale AR, Bevis P, Neary WD et al. Radiocephalic and brachiocephalic arteriovenous fistula outcomes in the elderly. J Vasc Surg. 2008; 47(1):144-50.
[9] Chan MR, Young HN, Becker YT, Yevzlin AS. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study. Semin Dial. 2008; 21(3):274-9.
[10] Fitzgerald JT, Schanzer A, Chin AI, McVicar JP, Perez RV, Troppmann C. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg. 2004; 139(2):201-8.
[11] Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002; 39(1):92-101.
[12] Nguyen TH, Bui TD, Gordon IL, Wilson SE. Functional patency of autogenous AV fistulas for hemodialysis. J Vasc Access. 2007; 8(4):275-80.
[13] Jennings WC, Kindred MG, Broughan TA. Creating radiocephalic arteriovenous fistulas: technical and functional success. J Am Coll Surg. 2009; 208(3):419-25.
[14] Revanur VK, Jardine AG, Hamilton DH, Jindal RM. Outcome for arterio-venous fistula at the elbow for haemodialysis. Clin Transplant. 2000; 14: 318-22.
]]> [15] Maya ID, O’Neal JC, Young CJ, Barker-Finkel J, Allon M. Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts. Clin J Am Soc Nephrol. 2009; 4(1):86-92.[16] Fitzgerald JT, Schanzer A, McVicar JP, Chin AI, Perez RV, Troppmann C. Upper arm arteriovenous fistula versus forearm looped arteriovenous graft for hemodialysis access: a comparative analysis. Ann Vasc Surg. 2005; 19(6):843-50.
[17] Bakken AM, Galaria II, Agerstrand C. et al. Percutaneous therapy to maintain dialysis access successfully prolongs functional duration after primary failure. Ann Vasc Surg. 2007;21(4):474-80.
[18] Hasegawa T, Elder SJ, Bragg-Gresham J. et al. Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2008;3(5):1373-8.
[19] Ackad A, Simonian GT, Steel K. et al. A journey in reversing practice patterns: a multidisciplinary experience in implementing KDOQI guidelines for vascular access. Nephrol Dial Transplant. 2005;20(7):1450-5.
[20] Hyland K, Cohen RM, Kwak A et al. Preoperative mapping venography in patients who require hemodialysis access: imaging findings and contribution to management. J Vasc Interv Radiol. 2008;19(7):1027-33.
[21] Moncef G. Surgical revision of failing or thrombosed native arteriovenous fistulas: a single center experience. Saudi J kidney Dis Transpl. 2010; 21(2):258-61.
[22] Shin SW, Do YS, Choo SW, Lieu WC, Choo IW. Salvage of immature arteriovenous fistulas with percutaneous transluminal angioplasty. Cardiovasc Intervent Radiol. 2005;28(4):434-8.
[23] Bhat R, McBride K, Chakraverty S, Vikram R, Severn A. Primary cutting balloon angioplasty for treatment of venous stenoses in native hemodialysis fistulas: long-term results from three centers. Cardiovasc Intervent Radiol. 2007;30(6):1166-70
[24] Song H, Won Y, Kim Y, Yoon S. Salvaging and maintaining non-maturing Brescia-Cimino haemodialysis fistulae by percutaneous intervention. 42. Ann Vasc Surg. 2008; 22(5):657-62.
]]> [25] Kim YC, Won JY, Choi SY. et al. Percutaneous treatment of central venous stenosis in hemodialysis patients: long-term outcomes. Cardiovasc Intervent Radiol. 2009;32(2):271-8.[26] Malik J, Tuka V, Kasalova Z. et al. Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access. 2008; 9(3):155-66.
[27] Derakhshanfar A, Gholyaf M, Niayesh A, Bahiraii S. Assessment of frequency of complications of arterio venous fistula in patients on dialysis: a two-year single center study from Iran. Saudi J Kidney Dis Transpl. 2009; 20(5):872-5.
[28] Suding PN, Wilson SE. Strategies for management of ischemic steal syndrome. Semin Vasc Surg. 2007; 20(3):184-8.
[29] Thermann F, Ukkat J, Wollert U, Dralle H, Brauckhoff M. Dialysis shunt-associated steal syndrome (DASS) following brachial accesses: the value of fistula banding under blood flow control. Langenbecks Arch Surg. 2007; 392(6):731-7.
[30] Woo K, CooK PR, Garg J, Hye RJ, Canty TG. Midterm results of a novel technique to salvage autogenous dialysis access in aneurysmal arteriovenous fistulas. J Vasc Surg. 2010;51(4): 921-5
Autor para correspondência: Cristina Freitas Serviço de Nefrologia do Hospital Santo António Largo Professor Abel Salazar, 4099-001 Porto, Portugal. Telefone: +351966481262 E-mail: crislmf@yahoo.com.br Fax: +351226066106
Dados apresentados na: III Reunião de Acessos Vasculares para Hemodiálise (Porto, 20 /03/2010)
]]>